Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma

Published:2012-09 Issue:3 Volume:126 Page:474-480
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

de Jong Renske A.,Kema Ido P.,Boerma Annemarie,Boezen H. Marike,der Want Johannes J.L. van,Gooden Marloes J.M.,Hollema Harry,Nijman Hans W.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference27 articles.

1. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase;Uyttenhove;Nat Med,2003

2. Plasma tryptophan, kynurenine and 3-hydroxykynurenine measurement using automated on-line solid-phase extraction HPLC-tandem mass spectrometry;de Jong;J. Chromatogr. B Analyt. Technol. Biomed Life Sci.,2009

3. IDO expression by dendritic cells: tolerance and tryptophan catabolism;Mellor;Nat. Rev. Immunol.,2004

4. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes;Munn;J Clin Invest,2004

5. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma;Riesenberg;Clin Cancer Res,2007

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL22 as an independent prognostic factor in endometrial cancer patients;Translational Oncology;2024-12

2. Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma;Modern Pathology;2024-08

3. Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors;Cancers;2023-03-29

4. Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer;Frontiers in Immunology;2022-09-02

5. “Iron triangle” of regulating the uterine microecology: Endometrial microbiota, immunity and endometrium;Frontiers in Immunology;2022-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3